Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsNASALStandard

ZOLMITRIPTAN

ZOLMITRIPTAN

Standard Dose
5MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview ZOLMITRIPTAN is listed in Drugs@FDA under application 212469 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLMITRIPTAN Form and strength SPRAY;NASAL - 5MG/SPRAY Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2021-09-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview ZOLMITRIPTAN is listed in Drugs@FDA under application 212469 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ZOLMITRIPTAN Form and strength SPRAY;NASAL - 5MG/SPRAY Sponsor PADAGIS ISRAEL Submission history Latest submission status date: 2021-09-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.